Strive, Inc. Files 8-K Report

TL;DR

Strive, Inc. (STRV) filed an 8-K on 9/23/25. Important for investors tracking the company.

AI Summary

On September 23, 2025, Strive, Inc. filed an 8-K report detailing other events and financial statements. The company, formerly known as Asset Entities Inc. until March 30, 2022, is incorporated in Nevada and headquartered in Dallas, Texas.

Why It Matters

This filing provides an update on Strive, Inc.'s corporate activities and financial reporting, which is important for investors to monitor the company's status.

Risk Assessment

Risk Level: low — This is a routine 8-K filing for other events and financial statements, not indicating any immediate significant risk.

Key Players & Entities

• Strive, Inc. (company) — Filer of the 8-K report
• Asset Entities Inc. (company) — Former name of Strive, Inc.
• March 30, 2022 (date) — Date of Strive, Inc.'s name change
• September 23, 2025 (date) — Earliest event date reported in the 8-K
• Nevada (jurisdiction) — State of incorporation for Strive, Inc.
• Dallas, Texas (location) — Location of Strive, Inc.'s principal executive offices

FAQ

Key Financial Figures

• $0.001 — hich registered Class A Common Stock, $0.001 par value per share ASST The Nasdaq

Filing Documents

• ea0258386-8k425_strive.htm (8-K) — 78KB
• ea025838601ex23-1_strive.htm (EX-23.1) — 3KB
• ea025838601ex99-3_strive.htm (EX-99.3) — 840KB
• ea025838601ex99-4_strive.htm (EX-99.4) — 54KB
• 0001213900-25-090815.txt ( ) — 1201KB
• asst-20250923.xsd (EX-101.SCH) — 3KB
• asst-20250923_lab.xml (EX-101.LAB) — 33KB
• asst-20250923_pre.xml (EX-101.PRE) — 22KB
• ea0258386-8k425_strive_htm.xml (XML) — 4KB

01 contains

Item 8.01 contains: 1. Historical

financial statements of Semler Scientific filed in accordance with Rule 3-05 of Regulation

financial statements of Semler Scientific filed in accordance with Rule 3-05 of Regulation S-X, included as Exhibits 99.1 and 99.2, which are incorporated herein by reference 2. Unaudited pro forma combined consolidated financial information of Strive and Semler Scientific in accordance with Article 11 of Regulation S-X giving effect to certain pro forma adjustments related to the pending merger transaction as if it were completed on January 1, 2024 as it relates to the unaudited pro forma combined consolidated statement of operations, and as if it were completed on June 30, 2025 as it relates to the unaudited pro forma combined consolidated balance sheet, included as Exhibit 99.3 hereto, which is incorporated herein by reference and 3. Supplementary risk factors related to the pending merger transaction, included as Exhibit 99.4, which is incorporated herein by reference. The pro forma information and related notes have been prepared for illustrative purposes only, based upon applicable rules of the Securities and Exchange Commission. The pro forma information does not purport to be indicative of what the combined company's consolidated financial position or results of operations actually would have been had the pending merger transaction been completed as of the dates indicated. In addition, the unaudited pro forma combined condensed financial information does not purport to project the future financial position or operating results of the combined company. The pro forma adjustments, which are subject to uncertainties, are based on the information available at the time of the preparation of these pro forma financial statements and on the basis of certain assumptions and estimates. The pro forma financial information should be read, if at all, with the related qualifications and other notes set forth in Exhibit 99.3. This Report does not modify or update the consolidated financial statements of Strive included in the Company's periodic reports. The historica

dilution

dilution caused by Strive's issuance of additional shares of its Class A common stock in connection with the proposed transaction; potential adverse reactions of Strive's or Semler Scientific's customers or changes to business or employee relationships, including those resulting from the announcement or completion of the proposed transaction; changes in Strive's or Semler Scientific's share price before closing; and other factors that may affect future results of Strive, Semler Scientific or the combined company. These factors are not necessarily all of the factors that could cause Strive's, Semler Scientific's or the combined company's actual results, performance or achievements to differ materially from those expressed in or implied by any of the forward-looking statements. Other factors, including unknown or unpredictable factors, also could harm Strive, Semler Scientific or the combined company's results. 2 Although each of Strive and Semler Scientific believes that its expectations with respect to forward-looking statements are based upon reasonable assumptions within the bounds of its existing knowledge of its business and operations, there can be no assurance that actual results of Strive or Semler Scientific will not differ materially from any projected future results expressed or implied by such forward-looking current report on Form 8-K filed with the Securities and Exchange Commission (the SEC) on September 12, 2025 (including the documents incorporated by reference therein), Semler Scientific's most recent annual report on Form 10-K for the fiscal year ended December 31, 2024 and quarterly reports on Form 10-Q, and other documents subsequently filed by Strive and Semler Scientific with the SEC. The actual results anticipated may not be realized or, even if substantially realized, they may not have the expected conseq

Financial Statements of Businesses Acquired

Financial Statements of Businesses Acquired As mentioned under Item 8.01 above, Strive is filing: (i) as Exhibit 99.1 to this Current Report on Form 8-K, the audited consolidated financial 2024, together with the notes related thereto and the Report of Independent Registered Public Accounting Firm thereon, (ii) as Exhibit 99.2, the interim unaudited condensed consolidated financial statements of Semler Scientific as of June 30, 2025 and for the three and six months ended June 30, 2025 and June 30, 2024, together with the notes related thereto; and (iii) as Exhibit 23.1, the consent of BDO USA, P.C., independent registered public accounting firm of Semler Scientific. (b) Pro Forma Financial Information As mentioned under Item 8.01 above, Strive is filing as Exhibit 99.3 to this Current Report on Form 8-K, the unaudited pro forma combined consolidated financial statements of Strive and Semler Scientific giving effect to certain pro forma adjustments related to the pending merger transaction between Strive and Semler Scientific as if it were completed on January 1, 2024 as it relates to the unaudited pro forma combined consolidated statement of operations, and as if it were completed on June 30, 2025 as it relates to the unaudited pro forma combined consolidated balance sheet. (c) Exhibits Exhibit No. Description 23.1 Consent of Independent Registered Public Accounting Firm to Semler Scientific, Inc. 99.1 Audited consolidated financial statements of Semler Scientific, Inc. as of December 31, 2024 and 2023, and for each of the two fiscal years in the period ended December 31, 2024, and the notes related thereto and the Report of Independent Registered Public Accounting Firm thereon (incorporated by reference to pages F-1 to F-30 of Semler Scientific, Inc.'s Annual Report on Form 10-K for the fiscal year ended Decembe

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the Company has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Date: September 23, 2025 Strive, Inc. /s/ Matthew Cole Name: Matthew Cole Title: Chief Executive Officer 5

View Full Filing

View this 8-K filing on SEC EDGAR